Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1062221rdf:typepubmed:Citationlld:pubmed
pubmed-article:1062221lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:1062221lifeskim:mentionsumls-concept:C0027950lld:lifeskim
pubmed-article:1062221lifeskim:mentionsumls-concept:C0017082lld:lifeskim
pubmed-article:1062221lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:1062221pubmed:issue2lld:pubmed
pubmed-article:1062221pubmed:dateCreated1976-5-25lld:pubmed
pubmed-article:1062221pubmed:abstractTextEight bands of gangliosides, from human polymorphonuclear leukocytes were demonstrated by thin-layer chromatography. Bands 4 and 5 were isolated and purified in sufficient amounts to allow their biochemical identification by thin-layer chromatography, gas chromatography and sequential action of glycosidases and neuraminidase. The major ganglioside was characterised as N-acetylneuraminylgalactosyl-beta-N-acetylglucosaminyl-beta-galactosyl-beta-glucosylceramide. A second ganglioside was tentatively identified as N-acetylneuraminyl-galactosyl-beta-N-acetylglucosaminyl-beta-(N-acetylneuraminyl)galactosyl-beta-glucosylceramide. Both gangliosides isolated were hydrolysed by neuraminidase. However, treatment of the intact cells with neuraminidase did not alter the ganglioside pattern.lld:pubmed
pubmed-article:1062221pubmed:languageenglld:pubmed
pubmed-article:1062221pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1062221pubmed:citationSubsetIMlld:pubmed
pubmed-article:1062221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1062221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1062221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1062221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1062221pubmed:statusMEDLINElld:pubmed
pubmed-article:1062221pubmed:monthFeblld:pubmed
pubmed-article:1062221pubmed:issn0006-3002lld:pubmed
pubmed-article:1062221pubmed:authorpubmed-author:HildebrandJJlld:pubmed
pubmed-article:1062221pubmed:authorpubmed-author:DacremontGGlld:pubmed
pubmed-article:1062221pubmed:issnTypePrintlld:pubmed
pubmed-article:1062221pubmed:day23lld:pubmed
pubmed-article:1062221pubmed:volume424lld:pubmed
pubmed-article:1062221pubmed:ownerNLMlld:pubmed
pubmed-article:1062221pubmed:authorsCompleteYlld:pubmed
pubmed-article:1062221pubmed:pagination315-22lld:pubmed
pubmed-article:1062221pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1062221pubmed:meshHeadingpubmed-meshheading:1062221-...lld:pubmed
pubmed-article:1062221pubmed:meshHeadingpubmed-meshheading:1062221-...lld:pubmed
pubmed-article:1062221pubmed:meshHeadingpubmed-meshheading:1062221-...lld:pubmed
pubmed-article:1062221pubmed:meshHeadingpubmed-meshheading:1062221-...lld:pubmed
pubmed-article:1062221pubmed:meshHeadingpubmed-meshheading:1062221-...lld:pubmed
pubmed-article:1062221pubmed:meshHeadingpubmed-meshheading:1062221-...lld:pubmed
pubmed-article:1062221pubmed:year1976lld:pubmed
pubmed-article:1062221pubmed:articleTitleCharacterization of two gangliosides from human leukemic polymorphonuclear leukocytes.lld:pubmed
pubmed-article:1062221pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1062221lld:pubmed